1-Methylindazole-3-carboxylic Acid: A Key Pharmaceutical Intermediate for Granisetron Synthesis
Discover the critical role of 1-Methylindazole-3-carboxylic acid, a high-purity intermediate essential for the production of Granisetron, a vital antiemetic medication. Explore its properties, applications, and why sourcing from reliable manufacturers in China is key for pharmaceutical success.
Get a Quote & SampleProduct Core Value
1-Methylindazole-3-carboxylic acid
1-Methylindazole-3-carboxylic acid (CAS 50890-83-0) is a critical building block in the pharmaceutical industry, primarily serving as a key intermediate in the synthesis of Granisetron hydrochloride. Granisetron is a widely recognized antiemetic drug, indispensable for managing nausea and vomiting induced by chemotherapy, radiotherapy, and post-operative treatments. As a trusted supplier in China, we ensure that this intermediate meets the stringent purity and consistency standards demanded by pharmaceutical manufacturing. Its reliable supply chain and consistent quality are paramount for ensuring the efficacy and safety of the final drug product.
- Pharmaceutical Synthesis: This compound is an indispensable component in the complex synthesis pathways required for producing Granisetron, a vital medication for cancer patients and post-operative recovery.
- High Purity Standards: Meeting rigorous pharmaceutical quality control, this intermediate boasts a high purity level, often exceeding 99%, with minimal impurities, ensuring the integrity of the final active pharmaceutical ingredient (API).
- Solubility and Stability: Its solubility in methanol facilitates its use in various organic synthesis reactions, while its stability under recommended storage conditions ensures its effectiveness as a reliable building block.
- Granisetron Intermediate: This chemical is specifically identified as Granisetron Impurity D or Granisetron Related Compound D, highlighting its direct relevance and crucial role in the quality assurance of Granisetron production.
Advantages of This Product
Consistent Quality and Purity
Sourced from leading manufacturers, our 1-Methylindazole-3-carboxylic acid consistently meets high purity specifications, crucial for the pharmaceutical industry's demanding standards, ensuring reliable outcomes in Granisetron synthesis.
Reliable Supply Chain
As a key pharmaceutical intermediate, a robust and dependable supply chain is essential. We are committed to providing a steady and timely supply, supporting your production schedules and ensuring uninterrupted manufacturing of antiemetic drugs.
Expertise in Pharmaceutical Intermediates
Leveraging deep industry knowledge, we understand the critical requirements for pharmaceutical intermediates. Our product's chemical properties and rigorous quality control align with the needs for synthesizing life-saving medications like Granisetron.
Key Applications
Pharmaceutical Synthesis
The primary application of 1-Methylindazole-3-carboxylic acid is as a vital intermediate in the synthesis of Granisetron, an essential drug for managing chemotherapy-induced nausea and vomiting, underscoring its importance in cancer supportive care.
Antiemetic Drug Production
This compound is a cornerstone for manufacturers producing antiemetic medications, contributing directly to the final API that helps patients maintain quality of life during demanding medical treatments.
Fine Chemical Manufacturing
Beyond its direct pharmaceutical use, it represents a significant product within the fine chemical sector, showcasing advanced organic synthesis capabilities and the production of high-value chemical intermediates.
Research and Development
Its role as Granisetron Impurity D also makes it valuable in pharmaceutical R&D for quality control, impurity profiling, and analytical method development related to Granisetron manufacturing and testing.